Home » Pipeline
Pipeline
Company | Drug/Device | Medical Condition | Status |
---|---|---|---|
Oppilan Pharma Ltd. | OPL-002 | inflammatory bowel disease (IBD) | Phase I trial initiated enrolling 72 subjects |
Pliant Therapeutics, Inc. | PLN-74809 | idiopathic pulmonary fibrosis | Phase I trial initiated enrolling 90 healthy subjects |
Deciphera Pharmaceuticals, Inc. | rebastinib in combination with carboplatin | advanced or metastatic solid tumors | Phase Ib/II trial initiated enrolling 117 subjects (18 subjects in Part 1 and 99 subjects in Part 2) |
Protagonist Therapeutics, Inc. | PTG-300 | beta thalassemia | Phase II trial initiated enrolling 84 adolescent and adult subjects |
Galapagos NV | GLPG1690 | systemic sclerosis (SSc, or scleroderma) | Phase IIa trial initiated enrolling 30 subjects with diffuse cutaneous SSc |
Urovant Sciences | vibegron | abdominal pain due to irritable bowel syndrome (IBS) | Phase IIa trial initiated enrolling 200 female subjects |
Seres Therapeutics, Inc. | SER-287 | active mild-to-moderate ulcerative colitis | Phase IIb trial initiated enrolling 200 subjects |
Pfizer, Inc. | PF-06651600 | moderate to severe alopecia areata | Phase IIb/III trial initiated enrolling 660 subjects |
NeuroBo Pharmaceuticals, Inc. | NB-01 | diabetic neuropathic pain | Phase III trial initiated enrolling 717 adult subjects at 80 sites in the U.S. |
Tivic Health Systems, Inc. | ClearUP | sinus pain due to allergic rhinitis (hay fever) | 510(k) clearance granted by the FDA |
StemCyte | Allogeneic Human Leukocyte Antigen (HLA)-Matched Umbilical Cord Blood Mononuclear Stem Cells (UCBMNC) (MC001) | spinal cord injury | IND approval granted by the FDA |
MicroVention, Inc. | WEB Aneurysm Embolization System | intracranial wide neck bifurcation aneurysms | PMA approval granted by the FDA |
Rainier Therapeutics, Inc. | vofatamab | advanced or metastatic urothelial cell carcinoma (bladder cancer) that is positive for FGFR3 mutation and/or fusion | Fast Track Designation granted by the FDA |
Grifols | Erytra Eflexis | blood grouping | Approval granted by the FDA |
Upcoming Events
-
23Apr
-
07May
-
14May